Safety of patients isolated for infection control

被引:422
作者
Stelfox, HT
Bates, DW
Redelmeier, DA
机构
[1] Brigham & Womens Hosp, Div Gen Med, Boston, MA 02120 USA
[2] Brigham & Womens Hosp, Dept Med, Boston, MA 02120 USA
[3] Univ Toronto, Dept Med, Toronto, ON, Canada
[4] Univ Toronto, Dept Hlth Policy Management & Evaluat, Toronto, ON, Canada
[5] Sunnybrook & Womens Coll Hlth Sci Ctr, Clin Epidemiol Unit, Toronto, ON, Canada
[6] Harvard Univ, Grad Sch Arts & Sci, Cambridge, MA 02138 USA
[7] Partners HealthCare Syst, Boston, MA USA
来源
JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION | 2003年 / 290卷 / 14期
关键词
D O I
10.1001/jama.290.14.1899
中图分类号
R5 [内科学];
学科分类号
1002 ; 100201 ;
摘要
Context Hospital infection control policies that use patient isolation prevent nosocomial transmission of infectious diseases, but may inadvertently lead to patient neglect and errors. Objective To examine the quality of medical care received by patients isolated for infection control. Design, Setting, and Patients We identified consecutive adults who were isolated for methicillin-resistant Staphylococcus aureus colonization or infection at 2 large North American teaching hospitals: a general cohort (patients admitted with all diagnoses between January 1, 1999, and January 1, 2000; n = 78); and a disease-specific cohort (patients admitted with a diagnosis of congestive heart failure between January 1, 1999, and July 1, 2002; n = 72). Two matched controls were selected for each isolated patient (n = 156 general cohort controls and n = 144 disease-specific cohort controls). Main Outcome Measures Quality-of-care measures encompassing processes, outcomes, and satisfaction. Adjustments for study cohort and patient demographic, hospital, and clinical characteristics were conducted using multivariable regression. Results Isolated and control patients generally had similar baseline characteristics; however, isolated patients were twice as likely as control patients to experience adverse events during their hospitalization (31 vs 15 adverse events per 1000 days; P<.001). This difference in adverse events reflected preventable events (20 vs 3 adverse events per 1000 days; P<.001) as opposed to nonpreventable events (11 vs 12 adverse events per 1000 days; P=.98). Isolated patients were also more likely to formally complain to the hospital about their care than control patients (8% vs 1%; P<.001), to have their vital signs not recorded as ordered (51% vs 31%; P<.001), and more likely to have days with no physician progress note (26% vs 13%; P<.001). No differences in hospital mortality were observed for the 2 groups (17% vs 10%; P=16). Conclusion Compared with controls, patients isolated for infection control precautions experience more preventable adverse events, express greater dissatisfaction with their treatment, and have less documented care.
引用
收藏
页码:1899 / 1905
页数:7
相关论文
共 36 条
  • [1] An alternative strategy for studying adverse events in medical care
    Andrews, LB
    Stocking, C
    Krizek, T
    Gottlieb, L
    Krizek, C
    Vargish, T
    Siegler, M
    [J]. LANCET, 1997, 349 (9048) : 309 - 313
  • [2] INCIDENCE OF ADVERSE DRUG EVENTS AND POTENTIAL ADVERSE DRUG EVENTS - IMPLICATIONS FOR PREVENTION
    BATES, DW
    CULLEN, DJ
    LAIRD, N
    PETERSEN, LA
    SMALL, SD
    SERVI, D
    LAFFEL, G
    SWEITZER, BJ
    SHEA, BF
    HALLISEY, R
    VANDERVLIET, M
    NEMESKAL, R
    LEAPE, LL
    [J]. JAMA-JOURNAL OF THE AMERICAN MEDICAL ASSOCIATION, 1995, 274 (01): : 29 - 34
  • [3] Brown L H, 1997, Prehosp Emerg Care, V1, P145, DOI 10.1080/10903129708958808
  • [4] Infection control - A problem for patient safety
    Burke, JP
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (07) : 651 - 656
  • [5] *CDCP, SEV AC RESP SYNDR SA
  • [6] A NEW METHOD OF CLASSIFYING PROGNOSTIC CO-MORBIDITY IN LONGITUDINAL-STUDIES - DEVELOPMENT AND VALIDATION
    CHARLSON, ME
    POMPEI, P
    ALES, KL
    MACKENZIE, CR
    [J]. JOURNAL OF CHRONIC DISEASES, 1987, 40 (05): : 373 - 383
  • [7] Garner Julia S., 1996, Infection Control and Hospital Epidemiology, V17, P53
  • [8] Risk factors for retained instruments and sponges after surgery
    Gawande, AA
    Studdert, DM
    Orav, EJ
    Brennan, TA
    Zinner, MJ
    [J]. NEW ENGLAND JOURNAL OF MEDICINE, 2003, 348 (03) : 229 - 235
  • [9] Harvard Medical Practice study, 1990, PAT DOCT LAW STUD ME, VI
  • [10] HICKSON G, 1997, LAW CONTEMP PROBL, V27, P8